|Day Low/High||58.55 / 59.08|
|52 Wk Low/High||45.69 / 60.07|
The Federal Reserve will steal focus from another onslaught of earnings in the coming week as investors remain wary over the central bank's rate-hike timetable.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced efficacy and safety data in previously untreated adults with HIV-1 infection for the company's investigational once-daily formulation of...
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced the U.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said that the U.
Earnings season is off to a good start. Here are five more stocks that could shoot higher this summer.
Celgene continues to sprinkle cash around the biotech sector, tying up with smaller companies for first-dibs access to potentially valuable drugs and technologies.
BMO Capital Markets downgrades the pharmaceutical giant ahead of Q2 earnings as pricing pressure mounts and other potential headwinds begin to emerge.
BMO Capital Markets downgraded Merck (MRK) stock to ‘market perform’ today.
Here are Monday's top research calls, including upgrades for Groupon and Humana, and downgrades for Monster Beverage and Merck.
Cramer shares his views on why he thinks this market is not finished. Facebook, Amazon and Netflix are among the stocks discussed.
TheStreet highlights 3 stocks pushing the drugs industry lower today.
An earlier rally lasted through the afternoon, pushing the S&P 500 and Dow Jones Industrial Average to close at fresh records.
Merck (MRK) announced that it would be laying off research and development employees at three east-coast sites.
You have to be impressed by the breadth of XNCR's pipeline and significant partnerships with major players.
TheStreet highlights 3 stocks pushing the drugs industry higher today.
Pfizer, Merck and GlaxoSmithKline are all producing blockbuster vaccines and have others in their pipelines.
Buying a 93% stake in Vallée SA for $400 million will enable it to surpass Ourofino SA in the South American nation and enhance its chances of being first globally.
Shares of Merck (MRK) are on the rise after the company announced a $400 million acquisition.
Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced it has executed an agreement to acquire a controlling interest in Vallée S.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Premier Inc.
Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.
The eventual negative implications of Brexit could be greater for health care companies that have sizable exposure to Europe.
This industry stalwart has proved its mettle by outperforming not just the broader market but also its peers. Here is why it belongs in investors' portfolios.